key: cord-1027116-xdkt3bx2
authors: Karaismailoglu, Eda; Karaismailoglu, Serkan
title: Two novel nomograms for predicting the risk of hospitalization or mortality due to COVID‐19 by the naïve Bayesian classifier method
date: 2021-03-01
journal: J Med Virol
DOI: 10.1002/jmv.26890
sha: c7d8688e9f385454c21e46702c2a366cf73d7479
doc_id: 1027116
cord_uid: xdkt3bx2

Coronavirus disease 2019 (COVID‐19) has become a global pandemic that has affected millions of people worldwide. The presence of multiple risk factors for COVID‐19 makes it difficult to plan treatment and optimize the use of medical resources. The aim of this study is to determine potential risk factors for hospitalization or mortality in patients with COVID‐19 via two novel naive Bayesian nomograms. The publicly available COVID‐19 National data published by the Mexican Ministry of Health through the “Dirección General de Epidemiología” website was analyzed. Univariable logistic regression was utilized to identify potential risk factors that may affect hospitalization or mortality in patients with COVID‐19. The naïve Bayesian classifier method was implemented to predict nomograms. The nomograms were verified by the area under the receiver operating characteristic curve (AUC), classification accuracy (CA), F1 score, precision, recall, and calibration plot. A total of 979,430 patients (45.3 ± 15.9 years old, and 51.1% male) tested positive for COVID‐19 from January 1 to November 22, 2020. Among them, 22.3% of the patients required hospitalization and 99,964 patients (9.8%) died. The most important risk factors to predict the probability of hospitalization and mortality were pneumonia, age, chronic kidney failure, chronic obstructive respiratory disease, and diabetes. The performance measures demonstrated good discrimination and calibration (hospitalization: AUC = 0.896, CA = 0.880; mortality: AUC = 0.903, CA = 0.899). Two novel nomograms to estimate the risk of hospitalization and mortality were proposed, which could be used to facilitate individualized decision‐making for patients newly diagnosed with COVID‐19.

A nomogram is a graphical representation method that has been used in medicine to predict the probability of any disease or risk of death through risk factors. This method provides the identification of the most important risk factors and calculation of the individualized prediction of disease according to the point values of each factor. 7 Statistical models, especially logistic regression or Cox proportional hazards regression are generally used to build a nomogram. On the other hand, the naïve Bayesian classifier is a powerful classification technique to compose predictive models despite simple and easy calculations. 8 It is based on Bayes' theorem with the assumption of conditional independence of features given the class. Although this feature seems to be a disadvantage, many studies have reported high classification accuracy (CA). [8] [9] [10] Park and Lee 11 compared Bayesian and logistic regression nomograms and showed the superiority of the naïve Bayesian approach.

This study, it was aimed to construct two novel nomograms using the naïve Bayesian classifier technique including demographics and comorbidities for the prediction of hospitalization or mortality in COVID-19 patients. The performance of the naïve Bayesian nomograms was evaluated by calibration and discrimination capability. To assess the calibration of the nomograms, a calibration plot was established which compares the agreement between predicted and actual probabilities. The area under the receiver operating characteristic (ROC) curve (AUC), CA, precision, recall, and F1 score were utilized to evaluate the accuracy of the classification.

In this study, the publicly available COVID-19 dataset was used released by the Mexican Ministry of Health via the "Dirección General de Epidemiología" website (https://www.gob.mx/salud/documentos/ datos-abiertos-152127). A total of 2,559,993 patients (over 18 years) were admitted to the hospitals on suspicion of COVID-19

in Mexico between January 1 and November 22, 2020. Twelve risk factors (features) were included in the analyses that were age, gender, smoking status, the presence of pneumonia, diabetes, obesity, hypertension, cardiovascular, chronic obstructive respiratory disease (CORD), chronic kidney failure, immunosuppressed, and asthma.

The naïve Bayesian classifier determines the probability for a particular class by using Bayes' theorem and assumes that the attribute values are independent of each other. Let C be a dependent binary variable where 0 indicates the other class and 1 the target class, X = {x 1 , x 2 ,…,x n } be a set of attributes. Based on Bayes theorem,

is the posterior probability of the target class. Therefore, the odds of C = 1 can be obtained as follows:

After taking log of odds, the Equation (2) transforms to logit,

where LR is the likelihood ratio. The summation term of the right side of Equation (3) is used for the construction of a nomogram that relates the feature values to the point score. It estimates the ratio of posterior to prior probability given the feature value x i . Finally, to get P(C = 1|X);

Equation (4) is the final probability value = P C X ( 1 | ) of C = 1 class when the attribute value is X. 

By using Equation (5), the points of each attribute (a ij ) are calculated as follows:

In Equation (6) for target class C. The numerator describes the log-likelihood ratio of the jth category in attribute i. As a result, the points line is constructed by Equation (6).

By using Equation (6), a ij for each category of attribute values can be calculated. The total points value is obtained by summing the points of the corresponding categories (Equation 7) and so, the total points line can be drawn.

The probabilities corresponding to the total points' values are obtained by substitution of Equation (7) into Equation (4).

A stratified 10-fold cross-validation method was implemented through the data training process. For this purpose, the data was divided into 10 folds. Onefold was considered as a test subset and ninefold as a training subset. Five different discrimination metrics were used which are ROC curve, CA, F1 score, precision, and recall.

Among them, the ROC curve is plotted against the 1-specificity for various cut-off points. As the curve close to the upper left corner of the graph, the probability of a true positive test result is higher than the probability of a false-negative test result. AUC, defined as the integral of the area between the ROC curve and the (1-specificity)

x-axis, is utilized to assess the accuracy. The AUC differs between 0.5 and 1.0, where 0.5 denotes bad discrimination and 1 denotes perfect discrimination. 12 There are two reference lines for "intervention-for-all patients" (light gray line) and "intervention-for-none" (thin black line) in the graph. A nomogram should be found superior to both references to justify being used in clinical practice. 14 (Figure 2A ).

The calibration curves verified a good consistency for predicting mortality and the perfect consistency for predicting hospitalization ( Figures 1C and 2C) . The discrimination of the constructed nomogram evaluated with the AUC, CA, F1, precision, and recall metrics showed an almost excellent performance ( Table 3 ). The clinical usefulness of the nomograms was evaluated by DCA. The analysis revealed that both nomograms had higher net benefit than "intervention-for-all-patients" or "intervention-for-none" as well as the nomogram in predicting hospitalization had more benefit than in predicting mortality ( Figures 1D and 2D ).

In this study, two novel nomograms for predicting the risk of hospitalization and mortality in COVID-19 patients were developed and validated. Although various nomograms have been developed by studies on COVID-19, we have analyzed a larger sample size (979,430 patients) via the naïve Bayesian classifier technique. [16] [17] [18] The predictive validity of the nomograms was verified with calibration and discrimination.

Although many studies have utilized logistic regression analysis for building nomograms, the naïve Bayesian nomogram has T A B L E 2 Univariable logistic regression analysis predicting hospitalization (Model 1) and mortality (Model 2) The results demonstrated that pneumonia and age factors had the greatest influence on hospitalization (range, −35 to 100) and mortality (range, −100 to 50), respectively. On the other hand, the smallest influencing factor was smoking status for both nomograms.

The most significant risk factor was pneumonia for hospitalization (100 points) and mortality (74.12 points). Coronavirus can affect higher mortality rate compared with individuals ages 54 years or younger. 24 This study indicated that common comorbidities were associated with COVID-19 related hospitalization and mortality. Although the presence of chronic kidney failure, CORD, cardiovascular, immunosuppressed risk factors increased the risk of COVID-19 for hospitalization or mortality, the absence of these risk factors had little or no effect. Conversely, the absence of diabetes, hypertension, obesity decreased the risk for both conditions. These comorbidities have been associated with COVID-19 in previous studies. [25] [26] [27] [28] In accordance with the literature, 29 our results showed that being male increased the risk of mortality. Interestingly, according to our analysis, the presence of asthma appears to be a risk-reducing factor, but its influencing factor was very small. Indeed, the relationship between asthma and COVID-19 is still uncertain. 30 Smoking does not seem to have a notable increasing or decreasing effect on risk factors in this study. Surprisingly, Farsalinos et al. 31 stated that nicotine may be considered as a potential treatment option.

This study has some limitations. The dataset lacks some information such as laboratory results and treatment of comorbidities, which could have been useful to better understand the clinical pattern of COVID-19. In conclusion, the proposed Bayesian nomograms can be used to assess patients with COVID-19 symptoms and to facilitate medical decision-making.

The authors declare that there are no conflict of interests.

The data that support the findings of this study are openly available in the Mexican Ministry of Health via the "Dirección General de Epidemiología" at https://www.gob.mx/salud/documentos/datosabiertos-152127.

http://orcid.org/0000-0003-3085-7809

Serkan Karaismailoglu http://orcid.org/0000-0002-6907-6500

A novel coronavirus from patients with pneumonia in China

Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis

Development and validation of a simplified nomogram predicting individual critical illness of risk in COVID-19: A retrospective study

Nomogram for predicting COVID-19 disease progression based on single-center data: observational study and model development

A predicting nomogram for mortality in patients with COVID-19. Front Public Health

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

Nomograms for visualization of naive Bayesian classifier

On the optimality of the simple Bayesian classifier under zero-one loss

Bayesian network classifiers

How to build nomogram for type 2 diabetes using a naïve Bayesian classifier technique

Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve

Discrimination and calibration of clinical prediction models: users' guides to the medical literature

A simple, step-by-step guide to interpreting decision curve analysis

How to build and interpret a nomogram for cancer prognosis

An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multicenter study

Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics

A nomogram to predict the risk of unfavourable outcome in COVID-19: a retrospective cohort of 279 hospitalized patients in Paris area

Novel nomogram based on risk factors of chronic obstructive pulmonary disease (COPD) using a naïve Bayesian classifier model

Respiratory follow-up of patients with COVID-19 pneumonia

The clinical and chest CT features associated with severe and critical COVID-19 pneumonia

Clinical characteristics and manifestations in older patients with COVID-19

CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) -United States

COVID-19 mortality risk for older men and women

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

COVID-19, cytokines, and immunosuppression: what can we learn from severe acute respiratory syndrome?

Systematic review and meta-analysis of sex-specific COVID-19 clinical outcomes

The relationship between severe or dead COVID-19 and asthma: A meta-analysis

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?

Two novel nomograms for predicting the risk of hospitalization or mortality due to COVID-19 by the naïve Bayesian classifier method